Hepatitis C: Know Your Status

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
Approximately 4 million people in the United States have hepatitis C. Many do not have any symptoms, so those who have risk factors for the disease should get tested. Symptoms, when they do appear, include itchiness, confusion, swelling of the belly and feet, and jaundice of the eyes and skin. Once these symptoms appear, serious damage may already have been done to the liver. The disease is curable, however, so if a patient tests positive, he or she can work with a doctor to map out a treatment plan.
 
To learn more, check out this video:

Related Articles
A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.
Gilead Sciences Inc. has reported positive results from its phase 2 and phase 3 studies on ledipasvir 90 mg/sofosbuvir 400 mg in patients with chronic hepatitis C virus.
A trio of studies from AbbVie provides good news for patients with hepatitis C virus, including those with comorbid HIV or cirrhosis.
A study exploring Merck’s experimental hepatitis C virus treatment has provided proof-of-concept for a 6- to 8-week course of triple therapy.
Latest Issues
$auto_registration$